IGHE and eosinophilic esophagitis: Fortunately, there are new therapeutic approaches to treat these patients, such as omalizumab, a monoclonal anti-IgE antibody, which has been in trial for patients with multiple food allergies, and eosinophilic esophagitis [59,60].